Mail & Guardian Online - November 30, 2007
Belinda Beresford
A panel of experts has advised the department of health and Sanac that the minimum should be two antiretrovirals to ensure the mother is protected from drug resistance.
The panel also recommended that pregnant women be given access to antiretroviral therapy when their CD4 count -- a measure of the strength of the immune system -- falls to 350. Therapy is normally given when the count is 200.
Starting pregnant women on antiretrovirals at an earlier stage is part of a global shift in treatment.
The Treatment Action Campaign (TAC) says at least two provinces are ready to implement such strategies, but have not done so yet because they are waiting for the green light from the national health department.
Mlambo-Ngcuka reportedly said provinces should go ahead as soon as they are ready.
071130
MG071106
Copyright © 2007 - Daily Mail & Guardian. For information about the content or for permission to redistribute, publish or use for broadcast, contact the publisher.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2007. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2007. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .